Technology Review - Published By MIT
Advertisement

TR Editors' blog

Insights, opinions, and our editors' analysis of the latest in emerging technologies.

Blog Topics

Recent Posts

Recent Comments

  • fiberman : How amusing. A contributor to the WSJ suggests eating your fellow man. Well, isn't that just what...
  • kstauff : I believe the deficit left by the Bush administration for fiscal '08 was around $500 billion. ...
  • kstauff : You're right, I overestimated the number of democrats in both houses, although I believe that the...
  • kstauff : Are you as angry at Roosevelt, Truman, Kennedy, Johnson and Clinton for the wars they prosecuted?...
  • kstauff : The Obama administration told us it would be 8% without the stimulus.  You tell me if he and his...
  • ... : Just to make it apparent, there's already a Chromium browser which uses the Chrome codebase for...
  • Adalast : people keep throwing around the "New Deal" and saying that it was horrible and didn't help our...
  • ... : All of these careful studies and delays in taking up a form of energy that is far superior to the...
  • Gary... :    While 10% unemployment is unacceptable, to say the stimulus did not help the employment...
  • skingw : History also tells us: too many human beings for too little resources --> great wars (killing a...
Advertisement
Friday, January 23, 2009

FDA Clears First Embryonic-Stem-Cell Therapy Trials

Geron will begin clinical trials of its therapy for spinal-cord injury this summer.
By Emily Singer
Repair work: This animation shows glial progenitor cells, made from human embryonic stem cells, repairing nerve damage. Credit: University of California, Irvine

Geron, a California-based cell-therapy company that has been working with embryonic stem cells for the last decade, finally received clearance from the U.S. Food and Drug Administration to begin clinical trials of its cell-based therapy for spinal-cord injury.

The trial is limited to eight patients with newly acquired spinal-cord injuries who will receive injections of the cell therapy, called GRNOPC1, within two weeks of their accident. GRNOPC1 is made by transforming embryonic stem cells into oligodendrocytes--a type of brain cell that wraps itself around neurons, forming a fatty insulation layer that allows electrical messages to be conducted throughout the nervous system. In many spinal-cord injuries, these cells are damaged, but the underlying nerve cells remain intact. These cells are then injected into the site of the injury, coating exposed nerves and restoring communication to the nervous system.

Scientists published the results of a successful study testing the therapy in animals in 2005, showing that paralyzed rats injected with the cells were able to walk again. Since then, Geron has been conducting numerous studies intended to show the safety of the cell-based therapy, as well as developing production methods that would make the cells as easy to use as more traditional treatments. Geron researchers have also developed a way to reliably freeze and thaw brain cells, so that they can be manufactured in a central location, and then shipped to the hospitals where they will be used.

Because embryonic-stem-cell-based therapies are so new, the FDA has had trouble deciding how to evaluate new drug applications. (Geron's president and CEO, Thomas Okarma, thought approval was imminent when I spoke with him in 2006. See "Human Tests of Embryonic Stem Cell Treatments Planned.") The initial trial is designed to assess safety, but doctors will also measure its effectiveness, such as improved neuromuscular control or sensation in the trunk or lower extremities.

The announcement comes amid general excitement in the stem-cell field, thanks to Barack Obama's promise to lift funding restrictions for embryonic-stem-cell research. (See "Braving Medicine's Frontier.")

Geron's Thomas Okarma said in a statement, "This marks the beginning of what is potentially a new chapter in medical therapeutics--one that reaches beyond pills to a new level of healing: the restoration of organ and tissue function achieved by the injection of healthy replacement cells. The ultimate goal for the use of GRNOPC1 is to achieve restoration of spinal cord function by the injection of hESC-derived oligodendrocyte progenitor cells directly into the lesion site of the patient's injured spinal cord."

This video illustrates how Geron's cell therapy works in rats.

Comments

  • awesome
    i cant wait until we get to see the first human being cured using stem cells actually get up and walk. it will be an amazing day for humanity.
    Rate this comment: 12345

    camdaddy09
    01/23/2009
    Posts:37
    Avg Rating:
    3/5
  • grnopc1 trials to begin
    A new day is dawning in biotech!
    Rate this comment: 12345

    yalegrad97
    01/23/2009
    Posts:1
    Avg Rating:
    4/5
  • It isn't a frog!
    As someone who was paralyzed by a crushed back and spinal cord, I would rather have been left a quadriplegic than to have received treatment derived from the cells of a sacrificial human being.
    My life is no more or less valuable than the unborn embryo.

    While President Bush did not ban embryonic stem cell research his ban on the use of federal funds for such work was the right decision. This led to successful treatments from adult stem cells as well as new ways to aquire them. In fact the data shows there is no scientific reason to produce and harvest human tissue as if the only value of these lives was utilitarian.
    Rate this comment: 12345

    kaphar
    01/27/2009
    Posts:2
    Avg Rating:
    3/5
  • Don't choose for everyone
    If you really are in a wheelchair, it is your choice to reject medical treatments, just as some religious people do. (Or no alcohol, no meat on Fridays, to sacrifice an ox etc.)

    Thank goodness, it is not up to you to decide what is right for everyone. My father was in a chair for 28 years and he would have given anything to get on and off a toilet like everyone else.

    I have no doubts that if your reverence for single celled life were put under close scrutiny, you would also be found to be hypocritical. I wonder if you’ve considered all the complexities surrounding the issues on your own? Or have you been guided by any “organizations” in your thinking.

    I respect your right to reject these and other technologies but I don’t respect you making the decision for all people with spinal cord injuries. Many people in difficult situations, such as oppressed women in other countries, "would rather stay in their burka" than be free to do as they like. Fine, let them stay under there, but don’t force all women to wear one.

    It's all a matter of conditioning, (some call it brain washing) and forgive me for saying so but as my post stinks of atheism, your post has the slight scent of religious fanaticism.

    I could be wrong.

    I’ll get off my soap box now, lol.
    Rate this comment: 12345

    johnberlitz
    01/30/2009
    Posts:1
    Avg Rating:
    4/5
Advertisement

Log In

Forgot your password?     Register »
Advertisement
Technology Review November/December 2009

Current Issue

Natural Gas Changes the Energy Map
The United States has vast supplies of this cleaner fossil fuel. But how should we use it?
•  Subscribe
Save 36%
•  Table of Contents
•  MIT News
» Gift Subscription
» Digital Subscription
» Reprints, Back Issues
» Subscribe
» Table of Contents
» MIT News

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.